Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PACS
BuyPremium GrowerFLAGPACS Group, Inc. · Healthcare · United States · $6.8B · Avg Vol: $32M/d
PACS Group has strong momentum at M84 but value at V39 is below the calibrated floor and quality Q56 is modest. Insider selling of 0.54% is separately adverse.
COMPANY DESCRIPTION
PACS Group, Inc. is a leading post-acute healthcare company that operates skilled nursing facilities, assisted living facilities, and independent living communities across the United States. The company's competitive moat is driven by its decentralized operating model, which empowers local administrators to optimize clinical outcomes and financial performance tailored to their specific communities. As a scaled operator in a highly fragmented industry, PACS Group is well-positioned to leverage its operational efficiencies and capitalize on the long-term demographic tailwinds of an aging U.S. population.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.4B | 3.1B | 4.1B | 5.3B | 29.7% | 5.6B | 5.8B | 6.4B | 9.8% |
| EPS | 1.00 | 0.76 | 0.38 | 1.23 | 7.1% | 1.71 | 1.71 | 1.85 | 22.5% |
| Shares | 147.8M | 147.8M | 155.2M | 156.6M | +6.0% | 158.3M | — | — | — |
| Debt | 1.9B | 2.8B | 3.5B | 3.5B | 21.7% | 3.4B | — | — | — |
| Equity | 63.6M | 96.1M | 709.6M | 946.8M | 145.9% | — | — | — | — |
| Op CF | 92.6M | 63.7M | 367.3M | 404.2M | 63.4% | 573.2M | — | — | — |
| Inv CF | -75.3M | -172.8M | -442.7M | -264.0M | — | — | — | — | — |
| Fin CF | 12.3M | 129.6M | 117.5M | -69.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PACS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PACS | PACS Group, Inc.(you) | $6.8B | 74 | Buy |
| LFST | LifeStance Health Group, Inc. | $4.7B | 80 | Buy |
| CHE | Chemed Corporation | $6.8B | 89 | Strong Buy |
| OPCH | Option Care Health, Inc. | $3.6B | 68 | Buy |
| UHS | Universal Health Services, Inc. | $10.1B | 89 | Strong Buy |
| ENSG | The Ensign Group, Inc. | $10.1B | 57 | Hold |
| CON | Concentra Group Holdings Parent, Inc. | $4.4B | 93 | Strong Buy |
| EHC | Encompass Health Corporation | $11.9B | 91 | Strong Buy |
| DVA | DaVita Inc. | $11.5B | 92 | Strong Buy |
| NHC | National HealthCare Corporation | $3.5B | 92 | Strong Buy |
Peer medians: ROE -30.2% · P/E 27.1x · Gross margin 58.3%